NCT05631886
- Conditions
- Disease Attributes, EphA2 Overexpression, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China
Clinical trial condition
EphA2 Overexpression
Explore clinical trials studying EphA2 Overexpression. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
EphA2 Overexpression trial results
Active, Not Recruiting
CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors
NCT05631899
- Conditions
- EphA2 Overexpression, KRAS G12C, KRAS G12D, +7 more
- Locations
-
- Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China